Table 3.

Comparison of HCC characteristics between genders

Tumor characteristic	Overall (n = 1716)	Male (n = 1373)	Female (n = 343)	P value
Numbers of lesion
Single	890 (52.7%)	685 (50.7%)	205 (60.8%)	<0.001
Multiple/diffuse	799 (47.3%)	667 (49.3%)	132 (39.2%)
Tumor diameters (mm), median (IQR)	36 (20–71)	39.5 (20–78)	30 (17–56.5)	0.038
Portal vein invasion	480 (30.6%)	419 (33.4%)	61 (19.4%)	<0.001
Lymph node involvement	129 (8%)	111 (8.6%)	18 (5.6%)	0.048
Distant metastases	174 (10.4%)	148 (11.0%)	26 (7.7%)	0.043
AFP, median (IQR)	79 (8–4123.5)	82 (8–544)	56 (7–1905.5)	0.57
BCLC
0/A	468 (30.7%)	348 (28.4%)	120 (39.7%)	<0.001
B/C/D	1058 (69.3%)	876 (71.6%)	182 (60.3%)
Treatment
Curative	534 (31.1%)	411 (29.9%)	123 (35.9%)	0.12
Non‐curative	390 (22.7%)	321 (23.4%)	69 (20.1%)
Best supportive care	510 (29.7%)	410 (29.9%)	100 (29.2%)